Pharmacological, Toxicological and Dose-Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium Difficile Associated Infection (CDI).
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01904-18
Full Text
Open PDFAbstract
Available in full text
Date
January 22, 2019
Authors
Publisher
American Society for Microbiology